CPT® Code 0739T

Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and intraprocedural temperature monitoring, thermal dosimetry, bladder irrigation, and magnetic field nanoparticle activation

The procedure described by CPT® Code 0739T involves the ablation of malignant prostate tissue using a magnetic field induction technique. This innovative approach utilizes a suspension of magnetic nanoparticles that are injected into targeted areas of the prostate tissue. The procedure is designed to effectively destroy tumor cells while preserving surrounding healthy tissue. During the ablation process, the patient remains conscious, allowing them to communicate their sensations and comfort levels to the physician, which is crucial for ensuring patient safety and comfort throughout the procedure. The physician relies on preoperative imaging, such as MRI, along with ultrasound guidance, to accurately place the necessary catheters that will hold temperature sensors for real-time monitoring during the treatment. The procedure also includes bladder irrigation, which is initiated to protect the bladder during the injection of the nanoparticle suspension. This irrigation continues until it is confirmed that no nanoparticles are present in the urethra, indicating that the procedure can proceed safely. The temperature sensors are strategically placed through the catheters to monitor the tissue temperature closely, ensuring that it remains within the target range necessary for effective ablation. The magnetic field is activated for approximately one hour, during which the physician continuously monitors the tissue temperatures to achieve successful tumor ablation.